Medication info
Artjeong

Artjeong

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Pale yellow, oblong, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200705596 · Notified 2007.05.16 · Insurance code 652604280

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Use the usual adult dose. However, in patients aged 75 years or older, oral administration of tramadol increased its elimination half-life by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, redosing this medicine after dialysis is not necessary to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older and adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute or chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Use the usual adult dose. However, in patients aged 75 years or older, oral administration of tramadol increased its elimination half-life by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, redosing this medicine after dialysis is not necessary to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older and adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication can put stress on the liver; therefore, individuals who regularly consume more than three glasses of alcohol daily should consult with a doctor or pharmacist before taking it. When taking this medication, there is a risk of serious rash or allergic reaction; if a skin rash or other hypersensitivity reactions occur, discontinue use immediately and consult a physician. This medication contains tramadol, which poses a risk of seizures; caution should be exercised if there is a history of seizures or if taking other medications that can induce seizures. Though rare, anaphylaxis, a serious allergic reaction, may occur while taking this medication; if sudden difficulty breathing or hives appear, seek emergency medical attention immediately. Patients with severe respiratory diseases may find it difficult to breathe while taking this medication, so it should only be administered in a medical setting. Taking this medication with benzodiazepines or alcohol may cause severe drowsiness, respiratory depression, or coma; therefore, caution is advised not to combine them. Patients with elevated intracranial pressure or head injuries have a risk of increased brain pressure when taking this medication and should use it cautiously under medical supervision. Tramadol can cause both psychological and physical dependence; therefore, caution is advised for long-term use, and it should not be abruptly discontinued without a doctor's guidance. Patients with liver dysfunction may experience liver damage from the acetaminophen component of this medication and should consult with their physician before use. Particular care should be taken for individuals with a very fast-acting enzyme called CYP2D6, as they may produce excessive active metabolites, which increases the risk of respiratory depression. This medication should not be used in children under 12 or in teenagers under 18 who have undergone tonsillectomy or adenoidectomy, and teens aged 12 to 18 should avoid use if there are special risk factors. This medication may induce sleep apnea and hypoxemia; thus, continuous monitoring for worsening symptoms is necessary, and doses should be reduced or discontinued as needed. Elderly patients or those at risk of hyponatremia should be closely monitored for symptoms of hyponatremia while taking this medication. This medication should not be administered to certain patients, for example, those who are allergic to the components, have severe respiratory depression, have head injuries, or are taking MAO inhibitors. There are many interactions with other medications; those taking other medications should consult with their healthcare provider, especially regarding MAO inhibitors, serotonin agents, CYP3A4 and CYP2D6 related drugs, benzodiazepines, and alcohol. This medication may cause drowsiness and dizziness; caution is advised when driving or operating machinery. In cases of overdose, serious respiratory depression, seizures, and liver damage may occur; therefore, it is essential to adhere to the prescribed dosage, and if overdose is suspected, immediate emergency treatment is required. When storing this medication, keep it in a sealed container that prevents air or moisture from entering, and store it at room temperature between 1 and 30 degrees Celsius to maintain its efficacy safely.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory impairment, tremors, dysesthesia, attention disorders, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, sweating, urinary disturbances, erectile dysfunction, weakness, chest pain, abnormal emotions, chills, chest discomfort, malaise, withdrawal syndrome, thirst, irritability, hot flashes, weight loss, increased serum creatinine, anaphylactic reactions, impact on unstable emotions, delirium, suicidal thoughts, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, hypoprothrombinemia, fatigue glutamic acidosis, hyponatremia, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, tension, worsening migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal renal function tests, oliguria, rash, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, appetite loss, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, arrhythmias, exacerbated hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, perceptual abnormalities, tinnitus, abnormal central nervous system reactions, paralytic ileus, cholecystitis, abnormal renal function tests, increased salivation, gastrointestinal bleeding, QT prolongation, respiratory depression, somnolence, coma, cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, and kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's efficacy safely.

Appearance and packaging

Appearance

Pale yellow, oblong, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.